The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement
Abstract
IMPORTANCE: The incidence of thyroid cancer detection has increased by 4.5% per year over the last 10 years, faster than for any other cancer, but without a corresponding change in the mortality rate. In 2013, the incidence rate of thyroid cancer in the United States was 15.3 cases per 100 000 persons. Most cases of thyroid cancer have a good prognosis; the 5-year survival rate for thyroid cancer overall is 98.1%. OBJECTIVE: To update the US Preventive Services Task Force (USPSTF) recommendation on screening for thyroid cancer. EVIDENCE REVIEW: The USPSTF reviewed the evidence on the benefits and harms of screening for thyroid cancer in asymptomatic adults, the diagnostic accuracy of screening (including neck palpation and ultrasound), and the benefits and harms of treatment of screen-detected thyroid cancer. FINDINGS: The USPSTF found inadequate direct evidence on the benefits of screening but determined that the magnitude of the overall benefits of screening and treatment can be bounded as no greater than small, given the relative rarity of thyroid cancer, the apparent lack of difference in outcomes between patients who are treated vs monitored (for the most common tumor types), and observational evidence showing no change in mortality over time after introduction of a mass screening program. The USPSTF found inadequate direct evidence on the harms of screening but determined that the overall magnitude of the harms of screening and treatment can be bounded as at least moderate, given adequate evidence of harms of treatment and indirect evidence that overdiagnosis and overtreatment are likely to be substantial with population-based screening. The USPSTF therefore determined that the net benefit of screening for thyroid cancer is negative. CONCLUSIONS AND RECOMMENDATION: The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (D recommendation).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Guide to Clinical Preventive Services
Wesley Allen, T. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,129
Gharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedus, L., Paschke, R., Valcavi, R., & Vitti, P. (2016) · Endocrine Practice · doi:10.4158/ep161208.gl · Cited by 1,272
Korea's Thyroid-Cancer “Epidemic” — Screening and Overdiagnosis
Ahn, H. S., Kim, H. J., & Welch, H. G. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1409841 · Cited by 1,236
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Ito, Y., Uruno, T., Nakano, K., Takamura, Y., Miya, A., Kobayashi, K., Yokozawa, T., Matsuzuka, F., Kuma, S., Kuma, K., et al. (2003) · Thyroid · doi:10.1089/105072503321669875 · Cited by 877
Ito, Y., Miyauchi, A., Kihara, M., Higashiyama, T., Kobayashi, K., & Miya, A. (2014) · Thyroid · doi:10.1089/thy.2013.0367 · Cited by 826
An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients
Ito, Y., Miyauchi, A., Inoue, H., Fukushima, M., Kihara, M., Higashiyama, T., Tomoda, C., Takamura, Y., Kobayashi, K., & Miya, A. (2010) · World Journal of Surgery · doi:10.1007/s00268-009-0303-0 · Cited by 811
Thyroid gland: US screening in a random adult population.
Brander, A., Viikinkoski, P., Nickels, J., & Kivisaari, L. (1991) · Radiology · doi:10.1148/radiology.181.3.1947082 · Cited by 494
Brown, A. P., Chen, J., Hitchcock, Y. J., Szabo, A., Shrieve, D. C., & Tward, J. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1154 · Cited by 384
Oda, H., Miyauchi, A., Ito, Y., Yoshioka, K., Nakayama, A., Sasai, H., Masuoka, H., Yabuta, T., Fukushima, M., Higashiyama, T., et al. (2016) · Thyroid · doi:10.1089/thy.2015.0313 · Cited by 332
Iyer, N. G., Morris, L. G. T., Tuttle, R. M., Shaha, A. R., & Ganly, I. (2011) · Cancer · doi:10.1002/cncr.26070 · Cited by 321
Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
Solans, R., Bosch, J., Galofré, P., et al. (2001) · PubMed · Cited by 232
Thyroid Cancer Survival in the United States: Observational Data From 1973 to 2005
Davies, L., & Welch, H. G. (2010) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archoto.2010.55 · Cited by 203
Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
Grewal, R. K., Larson, S. M., Pentlow, C. E., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.061382 · Cited by 144
Jeong, S. Y., Kim, H. W., Lee, S., Ahn, B., & Lee, J. (2012) · Thyroid · doi:10.1089/thy.2012.0106 · Cited by 143
Salivary Gland Toxicity after Radioiodine Therapy for Thyroid Cancer
Hyer, S. L., Kong, A. H., Pratt, B. E., & Harmer, C. (2006) · Clinical Oncology · doi:10.1016/j.clon.2006.11.005 · Cited by 130
Thyroid gland: US screening in middle-aged women with no previous thyroid disease.
Brander, A., Viikinkoski, P., Nickels, J., et al. (1989) · Radiology · doi:10.1148/radiology.173.2.2678263 · Cited by 98
Kim, J. Y., Lee, C. H., Kim, S. Y., Jeon, W. K., Kang, J. H., An, S. K., & Jun, W. S. (2008) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2008.27.2.215 · Cited by 81
Needle Tract Implantation of Papillary Thyroid Carcinoma after Fine‐needle Aspiration Biopsy
Ito, Y., Tomoda, C., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Matsuzuka, F., Kuma, K., & Miyauchi, A. (2005) · World Journal of Surgery · doi:10.1007/s00268-005-0086-x · Cited by 75
Abu‐Yousef, M. M., Larson, J. H., Kuehn, D. M., et al. (2011) · Ultrasound Quarterly · doi:10.1097/ruq.0b013e31822b5681 · Cited by 56
Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
Lee, Y. S., Lim, H., Chang, H., et al. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.5.676 · Cited by 51
Adult health checkup: Update on the Preventive Care Checklist Form©.
Ridley, J., Ischayek, A., Dubey, V., & Iglar, K. (2012) · Europe PMC (PubMed Central) · Cited by 21
Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma
Ish‐Shalom, S., Durleshter, L., Segal, E., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0634 · Cited by 16
Kim, S. J., Moon, W. K., & Cho, N. (2010) · Acta Radiologica · doi:10.3109/02841851003641834 · Cited by 13
Ryu, C. H., Ryu, J., Ryu, Y. M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161463 · Cited by 8
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Metadata
- Authors
- US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Barry, M. J., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., Krist, A. H., Kurth, A. E., Landefeld, C. S., Mangione, C. M., Phipps, M. G., Silverstein, M., Simon, M. A., Siu, A. L., & Tseng, C.-W.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2017-05-09
- Volume
- 317
- Issue
- 18
- Pages
- 1882
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2964933269
- Cited by
- 313
- References
- 27
- FWCI
- 19.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.